Immutep (IMMP) announces an upcoming poster presentation for the TACTI-004 Phase III trial. The poster will be presented at the European Lung ...

Harry H. Yoon, MD, MHS, discusses tislelizumab and platinum-containing chemotherapy in unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1 at a level of 1 or ...

The greater the number of risk factors in patients with cutaneous squamous cell carcinoma, the higher the likelihood of poor ...

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer ...

Teddi Mellencamp is keeping things friendly with her ex. Amid her ongoing cancer battle, the Real Housewives of Beverly Hills ...

While HPV prevention efforts have largely focussed on women, the virus poses significant health risks to men as well ...

US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz ...

A recent study from Yale University has shed light on how different factors contribute to DNA mutations that drive cancer ...

The addition of AK104 to concurrent chemoradiotherapy improved survival outcomes for patients with locally advanced cervical ...

Dogs that have oral squamous cell carcinomas often need surgery that disfigures their jaws and lower their quality of ...

After nine months in space, Suni Williams and Butch Wilmore splashed back down the earth. Their bodies and minds may never ...